Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure.

Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure. Abstract Text:

BACKGROUND: Connective tissue growth factor (CTGF) has been recently reported as a mediator of myocardial fibrosis; however, the significance of plasma CTGF concentration has not been evaluated in patients with heart failure. The aim of this study was to investigate the clinical utility of plasma CTGF concentration for the diagnosis of heart failure. METHODS AND RESULTS: We evaluated fifty-two patients with chronic heart failure. The plasma concentration of CTGF and other markers of fibrosis were assessed and compared with clinical and echocardiographic data. Plasma CTGF was significantly elevated in symptomatic patients in proportion to their NYHA classes and was significantly correlated with plasma brain natriuretic peptide (BNP) concentration (r=0.395, P<0.01). Plasma CTGF was also correlated with plasma transforming growth factor beta (TGF-beta) (r=0.512, P<0.01), matrix metalloproteinase (MMP)-2 (r=0.391, P<0.05) and tissue inhibitor of MMP (TIMP)-2 (r=0.354, P<0.05) concentrations. Interestingly, plasma CTGF was correlated with E/E' value evaluated by tissue Doppler echocardiography (r=0.593, P=0.012), but not with systolic function and left ventricular mass. CONCLUSION: Our study suggests that plasma CTGF concentration is a novel diagnostic marker for cardiac dysfunction and may provide additional specific information about myocardial fibrosis in chronic heart failure patients.

Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure. Publishing Authors By Initials

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: European journal of heart failure : journal of the

VOLUME: 10

Page Numbers: 373-9

Journal Abbreviation: Eur. J. Heart Fail.

ISSN: 1388-9842

DAY: 11

MONTH: 03

YEAR: 2008

Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 100887595

Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure.

AFFILIATION: Department of Medicine and Biological Science, Gunma University Graduate School of Medicine, Japan.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Eur J Heart Fail

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure Related Publications

• A potential pitfall of MR imaging for assessing mandibular invasion of squamous cell carcinoma in the oral cavity.
• Additive effects of spironolactone and candesartan on cardiac sympathetic nerve activity and left ventricular remodeling in patients with congestive heart failure.
• An investigation of magnetic resonance imaging features in 14 patients with synovial chondromatosis of the temporomandibular joint.
• Changes in horizontal jaw position and intraoral pressure.
• Effect of atrial natriuretic peptide on left ventricular remodelling in patients with acute myocardial infarction.
• Effects of aging, menopause, and hormone replacement therapy on forearm skin elasticity in women.
• Evaluation of cardiac sympathetic nerve activity and left ventricular remodelling in patients with dilated cardiomyopathy on the treatment containing carvedilol.
• Imaging of epithelial cancer in sub-terahertz electromagnetic wave.
• Insulin Resistance in Patients with Stroke is Related to Visceral Fat Obesity and Adipocytokines.
• Lentiviral Vector-mediated SERCA2 Gene Transfer Protects Against Heart Failure and Left Ventricular Remodeling After Myocardial Infarction in Rats.
• Long-term nicorandil therapy improves cardiac sympathetic nerve activity after reperfusion therapy in patients with first acute myocardial infarction.
• MRI and clinical findings of posterior disk displacement in the temporomandibular joint.
• MRI findings of temporomandibular joints with disk perforation.
• Mechanisms and clinical implications of asymptomatic mitral regurgitation in patients with left ventricular dysfunction.
• Network structure for control of coupled multiple nonlinear oscillators.
• Plasma connective tissue growth factor is a novel potential biomarker of cardiac dysfunction in patients with chronic heart failure.
• Prognostic value of serial cardiac 123I-MIBG imaging in patients with stabilized chronic heart failure and reduced left ventricular ejection fraction.
• Prostaglandin F(2alpha) Inhibits SERCA2 Gene Transcription Through an Induction of Egr-1 in Cultured Neonatal Rat Cardiac Myocytes.
• Relationship between Carotid Atherosclerosis and Lumbar Spine Bone Mineral Density in Postmenopausal Women.
• Relationship between brachial arterial endothelial function and lumbar spine bone mineral density in postmenopausal women.
• Relationship between metabolic syndrome and sleep-disordered breathing in patients with cardiovascular disease--metabolic syndrome as a strong factor of nocturnal desaturation.
• Runx2 represses myocardin-mediated differentiation and facilitates osteogenic conversion of vascular smooth muscle cells.
• [A case of HLA-DR8 positive sarcoidosis following polymyositis and Sjögren's syndrome]
• [A case of Wegener's granulomatosis associated with the syndrome of inappropriate secretion of ADH]
• [A case of allergic bronchopulmonary aspergillosis that itraconazole showed a definite effect temporarily]
• [A case of anaphylactoid purpura associated with nephrosis followed by pulmonary tuberculosis]
• [A case of small cell lung carcinoma complicated by Lambert-Eaton myasthenic syndrome]
• [New evidence of conjugated estrogen and 17beta-estradiol]
• [Oxidative stress and mild hypertension]